icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
eNq1mF1v2jAUhu/5FVEudkdC+FjpllBtrN2QWo3Rok27QSY5FDNjp/7gY79+DqErnRy1M/gycfKeY5/jx68cX2yWxFsBF5jRxI+Chu8BTVmG6X3ij++u6l3/oleLF2iFDj47CxpB1PS9lCAhEr8YDaaAqAh+3Fx/Av0/cL9X82I2XUAqn32nJCbBFyTmNygvvvHiFcOZtwQ5Z1ni50ru3nqxkFxn0Vsz/kvkKIU43L85HF1M2ofv47AQe4WqEsCvEb03igK10kwV50BlH0m4Z3xbkW/LShuLEQimeApDJOdDzlY4g8wYYoaIAKsgs3V2C3xFQBZBjOLhIl0KK3G0QJsRPAzMSX/Qo325kfVGPTrrNJvd6LzTjrodq1D8YKnMVdCTCNNJ1Om0261WCDSELQFkWZkh4xIRRzXBov+8rRzF4fDwYu0zLHKCtsFC5LZLhTjSw8D15nc3kWIGd1zjiOg1+0efKkLC/8x6vIeFo4wLFvWZorKCGVcj24XoMyphU11RO8zJzb4XMYjTyf5m1Iz4oZoSnNoCTSNHgZDj0aCaZ6dDwUckYMzdseA7phlbi9Mz5rCmjrLPd5g0iuY8iybN8+5bXQbrLfRTN1DF6XKpOMsh1PTB4hioDOiMHYsT3ZNmqceOPFEz7hwOSxGBCo9Tt+SK7sJHS+asz93toXLAKPr58s62Ob4p4Nvb3aNRGmfJ37LaQdcFyXUrvpR4uWmTfNJqdLrnrfYbtMzfP5rnxNIol6JOfLLiZsLMpczFuzCcI1EXSK9lMONV7L8wTvoUE9egfaqjOxPv5NgvbVAJWUepT8vT8/UFtN2uL5mCY43u/v+9oTbGkFzBEXUoye6Mv4PL0yP9yeU6S3v4DCzuwuwcKZKYUVdeSU2NiscdIrqu9IprOHydzXDFhUplX8ZheZnTq8VhcZHTq/0BNyD5oQ==
qq0kUZty29pcBs4j
Listen
